• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在香港大流行前阶段,由于 SARS-CoV-2 导致的 2019 年冠状病毒病(COVID-19)医院内传播的情况并不存在。

Absence of nosocomial transmission of coronavirus disease 2019 (COVID-19) due to SARS-CoV-2 in the prepandemic phase in Hong Kong.

机构信息

Department of Microbiology, Queen Mary Hospital, Hong Kong Special Administrative Region, China; Infection Control Team, Queen Mary Hospital, Hong Kong West Cluster, Hong Kong Special Administrative Region, China.

Infection Control Team, Queen Mary Hospital, Hong Kong West Cluster, Hong Kong Special Administrative Region, China.

出版信息

Am J Infect Control. 2020 Aug;48(8):890-896. doi: 10.1016/j.ajic.2020.05.018. Epub 2020 May 24.

DOI:10.1016/j.ajic.2020.05.018
PMID:32461068
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7246012/
Abstract

BACKGROUND

To describe the infection control strategy to achieve zero nosocomial transmission of symptomatic coronavirus disease (COVID-19) due to SARS-CoV-2 during the prepandemic phase (the first 72 days after announcement of pneumonia cases in Wuhan) in Hong Kong.

METHODS

Administrative support with the aim of zero nosocomial transmission by reducing elective clinical services, decanting wards, mobilizing isolation facilities, providing adequate personal protective equipment, coordinating laboratory network for rapid molecular diagnosis under 4-tier active surveillance for hospitalized patients and outpatients, and organizing staff forum and training was implemented under the framework of preparedness plan in Hospital Authority. The trend of SARS-CoV-2 in the first 72 days was compared with that of SARS-CoV 2003.

RESULTS

Up to day 72 of the epidemic, 130 (0.40%) of 32,443 patients being screened confirmed to have SARS-CoV-2 by reverse transcription polymerase chain reaction. Compared with SARS outbreak in 2003, the SARS-CoV-2 case load constituted 8.9% (130 SARS-CoV-2/1458 SARS-CoV) of SARS-CoV infected cases at day 72 of the outbreak. The incidences of nosocomial acquisition of SARS-CoV per 1,000 SARS-patient-day and per 100 SARS-patient-admission were 7.9 and 16.9, respectively, which were significantly higher than the corresponding incidences of SARS-CoV-2 (zero infection, P <.001).

CONCLUSIONS

Administrative support to infection control could minimize the risk of nosocomial transmission of SARS-CoV-2.

摘要

背景

描述在香港大流行前阶段(武汉宣布出现肺炎病例后的头 72 天),为实现零院内传播有症状的 2019 冠状病毒病(COVID-19),针对严重急性呼吸系统综合征冠状病毒 2(SARS-CoV-2)而采取的感染控制策略。

方法

医管局在准备计划框架下,实施行政支援,以达到零院内传播的目标,包括减少非紧急临床服务、转科、调动隔离设施、提供足够的个人防护装备、协调医院病人和门诊病人的四级主动监测下的快速分子诊断实验室网络,以及组织员工论坛和培训。对 SARS-CoV-2 于前 72 天的趋势与 2003 年 SARS-CoV 的趋势进行了比较。

结果

在疫情暴发的第 72 天,对 32443 名接受筛查的患者中,有 130 名(0.40%)经逆转录聚合酶链反应证实携带 SARS-CoV-2。与 2003 年 SARS 暴发相比,SARS-CoV-2 病例占暴发第 72 天 SARS-CoV 感染者的 8.9%(130 例 SARS-CoV-2/1458 例 SARS-CoV)。每 1000 个 SARS 患者日和每 100 个 SARS 患者入院的 SARS-CoV 院内获得发生率分别为 7.9 和 16.9,明显高于 SARS-CoV-2(零感染,P<0.001)。

结论

感染控制的行政支援可最大程度降低 SARS-CoV-2 院内传播的风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e75c/7246012/c1bb22fbb534/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e75c/7246012/9a31f5406d1e/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e75c/7246012/588f2f0f67b3/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e75c/7246012/c1bb22fbb534/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e75c/7246012/9a31f5406d1e/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e75c/7246012/588f2f0f67b3/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e75c/7246012/c1bb22fbb534/gr3_lrg.jpg

相似文献

1
Absence of nosocomial transmission of coronavirus disease 2019 (COVID-19) due to SARS-CoV-2 in the prepandemic phase in Hong Kong.在香港大流行前阶段,由于 SARS-CoV-2 导致的 2019 年冠状病毒病(COVID-19)医院内传播的情况并不存在。
Am J Infect Control. 2020 Aug;48(8):890-896. doi: 10.1016/j.ajic.2020.05.018. Epub 2020 May 24.
2
Escalating infection control response to the rapidly evolving epidemiology of the coronavirus disease 2019 (COVID-19) due to SARS-CoV-2 in Hong Kong.因 SARS-CoV-2 导致的 2019 冠状病毒病(COVID-19)在香港的流行病学迅速演变,感染控制应对措施不断升级。
Infect Control Hosp Epidemiol. 2020 May;41(5):493-498. doi: 10.1017/ice.2020.58. Epub 2020 Mar 5.
3
Risk of nosocomial transmission of coronavirus disease 2019: an experience in a general ward setting in Hong Kong.2019 年冠状病毒病在医院环境中的传播风险:香港普通病房的经验。
J Hosp Infect. 2020 Jun;105(2):119-127. doi: 10.1016/j.jhin.2020.03.036. Epub 2020 Apr 4.
4
Surveillance of SARS-CoV-2 infection among frontline health care workers in Wuhan during COVID-19 outbreak.COVID-19 疫情期间武汉一线医护人员中 SARS-CoV-2 感染的监测。
Immun Inflamm Dis. 2020 Dec;8(4):840-843. doi: 10.1002/iid3.340. Epub 2020 Aug 20.
5
Maintaining Zero Coronavirus Disease 2019 Infection Among Long-Term Care Facility Residents in Hong Kong.香港长期护理机构居民中维持2019冠状病毒病零感染
J Am Med Dir Assoc. 2020 Jul;21(7):981-982. doi: 10.1016/j.jamda.2020.05.042. Epub 2020 May 29.
6
Stepping up infection control measures in ophthalmology during the novel coronavirus outbreak: an experience from Hong Kong.在新型冠状病毒疫情期间加强眼科感染控制措施:来自香港的经验。
Graefes Arch Clin Exp Ophthalmol. 2020 May;258(5):1049-1055. doi: 10.1007/s00417-020-04641-8. Epub 2020 Mar 3.
7
Challenges and countermeasures in the prevention of nosocomial infections of SARS-CoV-2 before resumption of work: Implications for the dermatology department.复工前新型冠状病毒医院感染预防的挑战与对策:对皮肤科的启示
J Am Acad Dermatol. 2020 Sep;83(3):961-963. doi: 10.1016/j.jaad.2020.05.131. Epub 2020 Jun 1.
8
Severe acute respiratory syndrome (SARS) and coronavirus disease-2019 (COVID-19): From causes to preventions in Hong Kong.严重急性呼吸系统综合症(SARS)和 2019 年冠状病毒病(COVID-19):香港的病因与预防。
Int J Infect Dis. 2020 May;94:156-163. doi: 10.1016/j.ijid.2020.03.059. Epub 2020 Apr 3.
9
Community Responses during Early Phase of COVID-19 Epidemic, Hong Kong.社区对新冠疫情初期的反应,香港。
Emerg Infect Dis. 2020 Jul;26(7):1575-1579. doi: 10.3201/eid2607.200500. Epub 2020 Jun 21.
10
Respiratory surveillance wards as a strategy to reduce nosocomial transmission of COVID-19 through early detection: The experience of a tertiary-care hospital in Singapore.呼吸监测病房作为一种通过早期检测来降低 COVID-19 医院内传播的策略:新加坡一家三级保健医院的经验。
Infect Control Hosp Epidemiol. 2020 Jul;41(7):820-825. doi: 10.1017/ice.2020.207. Epub 2020 May 8.

引用本文的文献

1
Infection of healthcare workers despite a high vaccination rate during the fifth wave of COVID-19 due to Omicron variant in Hong Kong.在香港第五波由奥密克戎变种引发的新冠疫情期间,尽管医护人员接种率很高,但仍出现了感染情况。
Infect Prev Pract. 2023 Mar;5(1):100261. doi: 10.1016/j.infpip.2022.100261. Epub 2022 Nov 29.
2
Evolution and Control of COVID-19 Epidemic in Hong Kong.香港 COVID-19 疫情的演变与控制。
Viruses. 2022 Nov 14;14(11):2519. doi: 10.3390/v14112519.
3
Metrics and indicators used to assess health system resilience in response to shocks to health systems in high income countries-A systematic review.

本文引用的文献

1
Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study.SARS-CoV-2 感染后口咽后唾液样本和血清抗体反应中的病毒载量时间特征:一项观察性队列研究。
Lancet Infect Dis. 2020 May;20(5):565-574. doi: 10.1016/S1473-3099(20)30196-1. Epub 2020 Mar 23.
2
Reasons for healthcare workers becoming infected with novel coronavirus disease 2019 (COVID-19) in China.中国医护人员感染2019新型冠状病毒病(COVID-19)的原因。
J Hosp Infect. 2020 May;105(1):100-101. doi: 10.1016/j.jhin.2020.03.002. Epub 2020 Mar 6.
3
用于评估高收入国家卫生系统应对卫生系统冲击的弹性的指标和指标——系统评价。
Health Policy. 2022 Dec;126(12):1195-1205. doi: 10.1016/j.healthpol.2022.10.001. Epub 2022 Oct 13.
4
Decreased Antibiotic Consumption Coincided with Reduction in Bacteremia Caused by Bacterial Species with Respiratory Transmission Potential during the COVID-19 Pandemic.在新冠疫情期间,抗生素使用量的减少与具有呼吸道传播潜力的细菌种类所导致的菌血症减少相吻合。
Antibiotics (Basel). 2022 May 31;11(6):746. doi: 10.3390/antibiotics11060746.
5
New Zealand Emergency Department COVID-19 Preparedness: a cross-sectional survey and narrative view.新西兰急诊科 COVID-19 准备情况:一项横断面调查和叙事观点。
BMJ Open. 2022 Feb 17;12(2):e053611. doi: 10.1136/bmjopen-2021-053611.
6
Complementation of contact tracing by mass testing for successful containment of beta COVID-19 variant (SARS-CoV-2 VOC B.1.351) epidemic in Hong Kong.通过大规模检测补充接触者追踪以成功控制香港的新冠病毒β变异株(SARS-CoV-2 VOC B.1.351)疫情。
Lancet Reg Health West Pac. 2021 Dec;17:100281. doi: 10.1016/j.lanwpc.2021.100281. Epub 2021 Oct 1.
7
COVID-19 false dichotomies and a comprehensive review of the evidence regarding public health, COVID-19 symptomatology, SARS-CoV-2 transmission, mask wearing, and reinfection.COVID-19 的错误二分法,以及对公共卫生、COVID-19 症状、SARS-CoV-2 传播、戴口罩和再感染的证据进行的全面回顾。
BMC Infect Dis. 2021 Jul 27;21(1):710. doi: 10.1186/s12879-021-06357-4.
8
COVID-19 case management strategies: what are the options for Africa?COVID-19 病例管理策略:非洲有哪些选择?
Infect Dis Poverty. 2021 Mar 17;10(1):30. doi: 10.1186/s40249-021-00795-7.
9
Infection control challenges in handling recurrent blockage of sewage pipes in isolation facility designated for patients with COVID-19.新冠病毒感染患者隔离设施中处理污水管道反复堵塞的感染控制挑战。
J Hosp Infect. 2021 Aug;114:187-189. doi: 10.1016/j.jhin.2021.03.002. Epub 2021 Mar 7.
10
Lessons learned 1 year after SARS-CoV-2 emergence leading to COVID-19 pandemic.SARS-CoV-2 引发 COVID-19 大流行一年后的经验教训。
Emerg Microbes Infect. 2021 Dec;10(1):507-535. doi: 10.1080/22221751.2021.1898291.
Improved Molecular Diagnosis of COVID-19 by the Novel, Highly Sensitive and Specific COVID-19-RdRp/Hel Real-Time Reverse Transcription-PCR Assay Validated and with Clinical Specimens.
新型高灵敏度和特异性 COVID-19-RdRp/Hel 实时荧光 RT-PCR 检测方法在临床标本中的验证及对 COVID-19 的分子诊断改良
J Clin Microbiol. 2020 Apr 23;58(5). doi: 10.1128/JCM.00310-20.
4
Escalating infection control response to the rapidly evolving epidemiology of the coronavirus disease 2019 (COVID-19) due to SARS-CoV-2 in Hong Kong.因 SARS-CoV-2 导致的 2019 冠状病毒病(COVID-19)在香港的流行病学迅速演变,感染控制应对措施不断升级。
Infect Control Hosp Epidemiol. 2020 May;41(5):493-498. doi: 10.1017/ice.2020.58. Epub 2020 Mar 5.
5
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.《武汉 2019 年新型冠状病毒感染的肺炎 138 例住院患者临床特征分析》
JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585.
6
Preparedness and proactive infection control measures against the emerging novel coronavirus in China.中国针对新型冠状病毒的防控及主动感染控制措施
J Hosp Infect. 2020 Mar;104(3):254-255. doi: 10.1016/j.jhin.2020.01.010. Epub 2020 Jan 18.
7
Prolonged delay for controlling KPC-2-producing Klebsiella pneumoniae outbreak: the role of clinical management.控制产KPC-2肺炎克雷伯菌暴发的长期延误:临床管理的作用
Am J Infect Control. 2015 Oct 1;43(10):1070-5. doi: 10.1016/j.ajic.2015.05.021. Epub 2015 Jul 11.
8
Infection control preparedness for human infection with influenza A H7N9 in Hong Kong.香港针对甲型H7N9流感病毒人间感染的感染控制准备工作。
Infect Control Hosp Epidemiol. 2015 Jan;36(1):87-92. doi: 10.1017/ice.2014.2.
9
Clinical management and infection control of SARS: lessons learned.严重急性呼吸综合征的临床管理和感染控制:经验教训。
Antiviral Res. 2013 Nov;100(2):407-19. doi: 10.1016/j.antiviral.2013.08.016. Epub 2013 Aug 28.
10
Infectious diseases in healthcare workers - an analysis of the standardised data set of a German compensation board.医务人员中的传染病——对德国赔偿委员会标准化数据集的分析。
J Occup Med Toxicol. 2012 Jul 13;7(1):8. doi: 10.1186/1745-6673-7-8.